Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solitary Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00626249
What this trial is testing

Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function

Who this might be right for
Mild NephropathyModerate NephropathyDiabetes Mellitus
Mannkind Corporation 36
Early research (Phase 1)Study completedNCT01459250
What this trial is testing

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT03873038
What this trial is testing

Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)

Who this might be right for
Renal DialysisKidney Failure, Chronic
Merck Sharp & Dohme LLC 38
Large-scale testing (Phase 3)Not Yet RecruitingNCT05596708
What this trial is testing

Study of Telitacicept in Patients With Refractory IgA Nephropathy

Who this might be right for
IgA Nephropathy
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Large-scale testing (Phase 3)UnknownNCT03521713
What this trial is testing

To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)

Who this might be right for
Anemia of Chronic Kidney Disease
Dong-A ST Co., Ltd. 214
Testing effectiveness (Phase 2)Looking for participantsNCT07053462
What this trial is testing

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Who this might be right for
End-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Large-scale testing (Phase 3)Looking for participantsNCT05935215
What this trial is testing

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 50
Early research (Phase 1)Study completedNCT04880291
What this trial is testing

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Who this might be right for
Kidney DiseasesDiabetic NephropathiesDiabetes Complications+2 more
Goldfinch Bio, Inc. 39
Early research (Phase 1)Study completedNCT03674476
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

Who this might be right for
NAFLDNonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Bristol-Myers Squibb 40
Testing effectiveness (Phase 2)Study completedNCT01843790
What this trial is testing

A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
La Jolla Pharmaceutical Company 120
Early research (Phase 1)Study completedNCT03214874
What this trial is testing

Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects

Who this might be right for
Congestive Heart FailureChronic Kidney Diseases
Sarfez Pharmaceuticals, Inc. 24
Early research (Phase 1)Study completedNCT00830674
What this trial is testing

KRN23 in X-linked Hypophosphatemia

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd. 42
Not applicableStudy completedNCT03791606
What this trial is testing

Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)

Who this might be right for
CIN
Kaiyang Lin 755
Early research (Phase 1)Ended earlyNCT06630247
What this trial is testing

A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid CancersSolid Tumor CancerSolid Tumor Malignancy+4 more
Exelixis 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578025
What this trial is testing

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
City of Hope Medical Center 34
Post-approval studies (Phase 4)Study completedNCT03794492
What this trial is testing

Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome

Who this might be right for
Kidney Transplant
Chong Kun Dang Pharmaceutical 169
Post-approval studies (Phase 4)Study completedNCT02229214
What this trial is testing

Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects

Who this might be right for
Obesity
VIVUS LLC 51
Testing effectiveness (Phase 2)Study completedNCT02093533
What this trial is testing

Eculizumab in Primary MPGN

Who this might be right for
Membranoproliferative Glomerulonephritis
Mario Negri Institute for Pharmacological Research 10
Not applicableStudy completedNCT07355907
What this trial is testing

Preoperative Prophylactic Fosfomycin Trometamol Versus 5-day Levofloxacin in Prevention of Postpercutaneous Nephrolithotomy Infectious Complications and Sepsis.

Who this might be right for
Calculi, RenalPCNLInfectious Complications
Tanta University 210
Next Page